ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ottavio Alfieri
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casati, V.
Right arrow Articles by Alfieri, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casati, V.
Right arrow Articles by Alfieri, O.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1999;68:2252-2256
© 1999 The Society of Thoracic Surgeons

Original Articles

Hemostatic effects of aprotinin, tranexamic acid and {epsilon}-aminocaproic acid in primary cardiac surgery

Valter Casati, MDa, Davide Guzzon, MDa, Michele Oppizzi, MDa, Mariangelo Cossolini, MDa, Giorgio Torri, MDa, Giliola Calori, MDb, Ottavio Alfieri, MDc

a Department of Cardiothoracic Anesthesia and Intensive Care, University of Milan, San Raffaele Hospital, Milan, Italy
b Epidemiology Unit, University of Milan, San Raffaele Hospital, Milan, Italy
c Department of Cardiac Surgery, University of Milan, San Raffaele Hospital, Milan, Italy

Address reprint requests to Dr Casati, Department of Cardiac Anesthesia, San Raffaele Hospital, Via Olgettina 60, 20132 Milan, Italy
e-mail: casati.valter{at}.hsr.it

Background. The effects of {epsilon}-aminocaproic acid (EACA) and tranexamic acid (TA) on bleeding and allogeneic transfusions, and the cost of pharmacological and transfusional treatment were compared to aprotinin (AP).

Methods. We randomized 210 patients subjected to elective cardiac surgery. Of these, 68 patients received EACA (a bolus of 5 g, an infusion of 2 g/h, and 2.5 g in the priming), 72 patients received TA (a bolus of 1 g, an infusion of 400 mg/h, and 500 mg in the priming), and 70 patients received AP (a bolus of 280 mg, an infusion of 70 mg/h, and 280 mg in the priming). Postoperative blood loss and homologous transfusions were collected and the cost of pharmacological treatment and homologous transfusions were calculated.

Results. Bleeding but not allogeneic transfusions was significantly higher in the EACA group (467 ± 234 versus TA, 311 ± 231 versus AP, 283 ± 233; p < 0.001). Costs of pharmacological and transfusional treatment were significantly lower in the TA group ($58.10 ± $105.10) versus the EACA group ($100.70 ± $158.60) versus the AP group ($432.60 ± $118.70) (p < 0.0001).

Conclusions. Compared to AP, TA has the same effects on bleeding and transfusions, but with a significant reduction of costs. Patients treated with EACA showed a significantly higher postoperative bleeding with an increased trend of transfusion requirement.


Related Article

Thomas F. Slaughter
Ann. Thorac. Surg. 1999 68: 2256-2257. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
A. F.L. Later, J. J. Maas, F. H.M. Engbers, M. I.M. Versteegh, E. F. Bruggemans, R. A.E. Dion, and R. J.M. Klautz
Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial
Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 322 - 329.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
H. Takagi, H. Manabe, N. Kawai, S.-n. Goto, and T. Umemoto
Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials
Interactive CardioVascular and Thoracic Surgery, July 1, 2009; 9(1): 98 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. E. Greilich, M. E. Jessen, N. Satyanarayana, C. W. Whitten, G. A. Nuttall, J. M. Beckham, M. H. Wall, and J. F. Butterworth
The Effect of Epsilon-Aminocaproic Acid and Aprotinin on Fibrinolysis and Blood Loss in Patients Undergoing Primary, Isolated Coronary Artery Bypass Surgery: A Randomized, Double-Blind, Placebo-Controlled, Noninferiority Trial
Anesth. Analg., July 1, 2009; 109(1): 15 - 24.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2008; 3(2008): 415 - 430.
[Full Text]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
A. Mehr-Aein, M. Sadeghi, and M. Madani-civi
Does Tranexamic Acid Reduce Blood Loss in Off-Pump Coronary Artery Bypass?
Asian Cardiovasc Thorac Ann, August 1, 2007; 15(4): 285 - 289.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
M. M Maddali and M. C Rajakumar
Tranexamic Acid and Primary Coronary Artery Bypass Surgery: a Prospective Study
Asian Cardiovasc Thorac Ann, August 1, 2007; 15(4): 313 - 319.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. R. Brown, N. J.O. Birkmeyer, and G. T. O'Connor
Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery
Circulation, June 5, 2007; 115(22): 2801 - 2813.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
V. Casati, P. Della Valle, S. Benussi, A. Franco, C. Gerli, P. Baili, O. Alfieri, and A. D'Angelo
Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques
J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 83 - 91.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
V. Casati, S. Benussi, L. Sandrelli, M. A. Grasso, S. Spagnolo, and A. D'Angelo
Intraoperative Moderate Acute Normovolemic Hemodilution Associated with a Comprehensive Blood-Sparing Protocol in Off-Pump Coronary Surgery
Anesth. Analg., May 1, 2004; 98(5): 1217 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2003; 2(2003): 389 - 400.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
D. Zabeeda, B. Medalion, M. Sverdlov, S. Ezra, A. Schachner, T. Ezri, and A. J. Cohen
Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization
Ann. Thorac. Surg., September 1, 2002; 74(3): 733 - 738.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
V. Casati, L. Sandrelli, G. Speziali, G. Calori, M. A. Grasso, and S. Spagnolo
Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study
J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1084 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. J. Despotis, M. S. Avidan, and C. W. Hogue Jr
Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
Ann. Thorac. Surg., November 1, 2001; 72(5): S1821 - 1831.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
V. Casati, C. Gerli, A. Franco, G. Torri, A. D'Angelo, S. Benussi, and O. Alfieri
Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study
Ann. Thorac. Surg., August 1, 2001; 72(2): 470 - 475.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. A. Ruel, F. Wang, M. E. Bourke, J.-Y. Dupuis, J. A. Robblee, W. J. Keon, and F. D. Rubens
Is tranexamic acid safe in patients undergoing coronary endarterectomy?
Ann. Thorac. Surg., May 1, 2001; 71(5): 1508 - 1511.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
V. Casati, D. Guzzon, M. Oppizzi, F. Bellotti, A. Franco, C. Gerli, M. Cossolini, G. Torri, G. Calori, S. Benussi, et al.
Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: Effects on perioperative bleeding and allogeneic transfusions
J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 520 - 527.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.